MULTISPECIFIC ANTIBODIES

The present invention relates to novel multispecific antibodies, their manufacture and use. The invention relates to a multispecific antibody of human IgG1, human IgG2, human IgG3 or human IgG4 subclass, comprising: a) the first light chain and the first heavy chain of a first antibody which specifi...

Full description

Saved in:
Bibliographic Details
Main Authors CHRISTIAN KLEIN, JOERG THOMAS REGULA, STEFAN KLOSTERMANN, WOLFGANG SCHAEFER, MICHAEL MOLHOJ, SABINE IMHOF-JUNG
Format Patent
LanguageEnglish
Published 15.07.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to novel multispecific antibodies, their manufacture and use. The invention relates to a multispecific antibody of human IgG1, human IgG2, human IgG3 or human IgG4 subclass, comprising: a) the first light chain and the first heavy chain of a first antibody which specifically binds to a first antigen; and b) the second light chain and the second heavy chain of a second antibody which specifically binds to a second antigen, and wherein the variable domains VL and VH in the second light chain and second heavy chain of the second antibody are replaced by each other; and wherein in the constant domain CL of the first light chain under a) the amino acid at position 124 is substituted independently by lysine (K) or arginine (R), and wherein in the constant domain CH1 of the first heavy chain under a) the amino acid at position 147 or the amino acid at position 213 is substituted independently by glutamic acid (E) or aspartic acid (D) (numbering according to Kabat EU index).
AbstractList The present invention relates to novel multispecific antibodies, their manufacture and use. The invention relates to a multispecific antibody of human IgG1, human IgG2, human IgG3 or human IgG4 subclass, comprising: a) the first light chain and the first heavy chain of a first antibody which specifically binds to a first antigen; and b) the second light chain and the second heavy chain of a second antibody which specifically binds to a second antigen, and wherein the variable domains VL and VH in the second light chain and second heavy chain of the second antibody are replaced by each other; and wherein in the constant domain CL of the first light chain under a) the amino acid at position 124 is substituted independently by lysine (K) or arginine (R), and wherein in the constant domain CH1 of the first heavy chain under a) the amino acid at position 147 or the amino acid at position 213 is substituted independently by glutamic acid (E) or aspartic acid (D) (numbering according to Kabat EU index).
Author CHRISTIAN KLEIN
WOLFGANG SCHAEFER
STEFAN KLOSTERMANN
JOERG THOMAS REGULA
SABINE IMHOF-JUNG
MICHAEL MOLHOJ
Author_xml – fullname: CHRISTIAN KLEIN
– fullname: JOERG THOMAS REGULA
– fullname: STEFAN KLOSTERMANN
– fullname: WOLFGANG SCHAEFER
– fullname: MICHAEL MOLHOJ
– fullname: SABINE IMHOF-JUNG
BookMark eNrjYmDJy89L5WSQ8A31CfEMDnB19nTzdFZw9AvxdPJ38XQN5mFgTUvMKU7lhdLcDHJuriHOHrqpBfnxqcUFicmpeakl8b6RhhZmxqaGjsYEFQAAFXEghA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID MY186351A
GroupedDBID EVB
ID FETCH-epo_espacenet_MY186351A3
IEDL.DBID EVB
IngestDate Fri Sep 06 06:11:45 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_MY186351A3
Notes Application Number: MY2016PI703594
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210715&DB=EPODOC&CC=MY&NR=186351A
ParticipantIDs epo_espacenet_MY186351A
PublicationCentury 2000
PublicationDate 20210715
PublicationDateYYYYMMDD 2021-07-15
PublicationDate_xml – month: 07
  year: 2021
  text: 20210715
  day: 15
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies F. HOFFMANN-LA ROCHE AG
RelatedCompanies_xml – name: F. HOFFMANN-LA ROCHE AG
Score 3.332935
Snippet The present invention relates to novel multispecific antibodies, their manufacture and use. The invention relates to a multispecific antibody of human IgG1,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Title MULTISPECIFIC ANTIBODIES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210715&DB=EPODOC&locale=&CC=MY&NR=186351A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMUtJNU0xSknTTQM2FnRNEpMsdC1SLIx1jS0STYFFQ5KpRSqoo-jrZ-YRauIVYRrBxJAO2wsDPie0HHw4IjBHJQPzewm4vC5ADGK5gNdWFusnZQKF8u3dQmxd1KC9Y2D_xdzQVM3FydY1wN_F31nN2dnWN1LNLwiYyYE1q6EjMwMrqA0NOmTfNcwJtCWlALk-cRNkYAsAGpVXIsTAlJonzMDpDLt2TZiBwxc62w1kQjNesQiDhG-oT4hncICrs6ebp7OCo1-Ip5M_qCknyiDn5hri7KELtCIe7pl430ioU4zFGFiAPfxUCQYFEzMLy7SkNBNzE4NEk1RDM4sUYCMq1dIw0TI1EdgjSZFkEMdhiBROGWkGLlB4gIYhDU1lGFhKikpTZYH1Z0mSHNjvABFzctI
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT4MwEL_MaZxvOj_m19yD4Y0oUqA8ELMVCChfUWa2JwJSjC9zcRj_fa-EqS97a9rk2l7yu7tf27sCXOsl18q7spIrDBZkkhdUpiVVZZXmGpqGQqNcEMUw0r0peZhpsw68rXNhmjqh301xRETUK-K9buz18u8Qy27eVq5uinfs-rh3U8uWWnaM_MVQNMmeWE4S2zGTGLPCuRQ9IcjRsyrjLdg2RGleETe9TERKyvK_P3H3YSdBUYv6ADp80YceW3-71ofdsL3txmYLvNUhDMJpkPrPicN812ejcZT6k1iEckcwdJ2UeTJOkf1uJgvn7VLUY-giw-cDGBGdmlVREYPc5oQrOi0xiOKmkps8R0ZSnsLJBiFnG0euoOelYZAFfvR4DntCN-JIUtEuoFt_fvFL9KV1MWz08AOXh3W_
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=MULTISPECIFIC+ANTIBODIES&rft.inventor=CHRISTIAN+KLEIN&rft.inventor=JOERG+THOMAS+REGULA&rft.inventor=STEFAN+KLOSTERMANN&rft.inventor=WOLFGANG+SCHAEFER&rft.inventor=MICHAEL+MOLHOJ&rft.inventor=SABINE+IMHOF-JUNG&rft.date=2021-07-15&rft.externalDBID=A&rft.externalDocID=MY186351A